Inflamafertin solution for injections 2 ml. №10

Description

Inflamafertin solution Storage
active substance: 1 ml of solution contains at least 5 mg of inflamafertin (regulatory peptides derived from placental tissue of cattle);

Excipients: sodium chloride, water for injections, quinozol.

Inflamafertin solution Dosage form
Solution for injection.

Main physical and chemical properties: clear liquid from light yellow to light brown.

Inflamafertin solution Pharmacotherapeutic group
Immunostimulants. ATX code L03A X.

Pharmacological properties

Pharmacodynamics.

The drug has an immunotropic effect: stimulates the functional capacity of phagocytes of mucous membranes and blood, enhances the synthesis of anti-inflammatory cytokines, affects the regulatory activity of lymphocyte subpopulations. In autoimmunoaggressive diseases or syndromes, it reduces the manifestations of immune-dependent inflammation, increases the number of CD4 + / 25 + – and CD8 + / 25 + cells, especially the level of IL-10 in the serum. The drug has a significant anti-inflammatory and resorbing effect, reduces the intensity of destructive, infiltrative and proliferative processes in the inflammatory focus. Accelerates the processes of epithelialization, regeneration, prevents the development of adhesions. Reducing the effects of edema and adhesions prevents the development of tubal infertility. In terms of its effect on the proliferative and exudative phases, the inflammation significantly exceeds the placenta extract.

Pharmacokinetics.

Inflamafertin® is a complex complex of regulatory peptides, part of which is present in the free state or in the form of high molecular weight precursor proteins in humans and animals, so the study of pharmacokinetic properties is not possible.

Indication
Prevention and treatment of female infertility caused by chronic inflammatory diseases (salpingitis, oophoritis, perioophoritis, salpingo-oophoritis, parametritis), as well as these pathological conditions that occur after abortion. Prevention and therapy of adhesions after operations on the pelvic organs. Treatment of early stages of autoimmune systemic diseases, including scleroderma and rheumatoid arthritis. Apply in the complex therapy of diseases based on the inflammatory component.

Contraindication
Increased individual sensitivity to the drug. Acute infections, history of allergy to animal proteins.